Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)
International Journal of Nephrology and Renovascular Disease · 2026-04 · Volume 19 · 1-12
DOI: 10.2147/ijnrd.s555573 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Nephrology and Renovascular Disease, 2026-04. Verfasst von Uday Jadhav und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Cardiac CT, MGM New Bombay Hospital, Mumbai, Maharashtra, India. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Cardiac CT, MGM New Bombay Hospital, Mumbai, Maharashtra, India.
- Department of Cardiology, Narayan Medical College, Jamuhar, Bihar, India.
- Department of General Medicine, Panchsheel Hospital, Delhi, India.
- Department of Medicine, College of Medicine & J.N.M. Hospital, Kalyani, West Bengal, India.
- Department of Internal Medicine, Gillurkar Multispeciality Hospital, Nagpur, Maharashtra, India.
- Department of General Medicine, MV Hospital & Research Center, Lucknow, Uttar Pradesh, India.
ORCID-Profile: Mukulesh Gupta, Sanjay Y Choudhari
Zitieren
APA
Jadhav, U., Guha, S., Mittal, H., Barik, C., Gillurkar, C. S., Gupta, S. K., Gupta, M., Saklecha, S., Jadhav, M., Choudhari, S. Y., Patil, S., Bhushan, S., A, D., & Barkate, H. (2026). Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). International Journal of Nephrology and Renovascular Disease, Volume 19, 1-12. https://doi.org/10.2147/ijnrd.s555573
Vancouver
Jadhav U, Guha S, Mittal H, Barik C, Gillurkar CS, Gupta SK, et al. Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). International Journal of Nephrology and Renovascular Disease. 2026;Volume 19:1-12. doi:10.2147/ijnrd.s555573
BibTeX
@article{Jadhav2026,
author = {Jadhav, Uday and Guha, Santanu and Mittal, Harsh and Barik, Chinmoy and Gillurkar, Chandrashekhar S and Gupta, Sandeep Kumar and Gupta, Mukulesh and Saklecha, Santosh and Jadhav, Mayur and Choudhari, Sanjay Y and Patil, Saiprasad and Bhushan, Sumit and A, Divakar and Barkate, Hanmant},
title = {Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)},
journal = {International Journal of Nephrology and Renovascular Disease},
year = {2026},
volume = {Volume 19},
pages = {1--12},
doi = {10.2147/ijnrd.s555573}
}
EUVIMED